Treatment of Erectile Dysfunction - Long Term Safety and Efficacy

NCT01065012 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1027

Enrollment

INDUSTRY

Sponsor class

Conditions

Erectile Dysfunction

Interventions

DRUG: Udenafil 50 mg
DRUG: Udenafil 100 mg
DRUG: Udenafil 150 mg
DRUG: Placebo Matching 50 mg Udenafil
DRUG: Placebo Matching 100 mg Udenafil
DRUG: Placebo Matching 150 mg Udenafil

Sponsor

Warner Chilcott